Logo image
Circulating microRNAs as biomarkers of alzheimer's disease: A systematic review
Journal article   Peer reviewed

Circulating microRNAs as biomarkers of alzheimer's disease: A systematic review

H.Z.Y. Wu, K.L. Ong, K. Seeher, N.J. Armstrong, A. Thalamuthu, H. Brodaty, P. Sachdev, K. Mather and M. Hornberger
Journal of Alzheimer's disease : JAD, Vol.49(3), pp.755-766
2015
url
Link to Published Version *Subscription may be requiredView

Abstract

Background: In recent years, microRNAs (miRNA), a class of non-coding RNA known to regulate protein expression posttranscriptionally, have been recognized as novel biomarkers of diseases. Objective: In this systematic review, we identify miRNAs that are differentially expressed in Alzheimer's disease (AD) and/or mild cognitive impairment (MCI) and evaluate their accuracy as potential blood biomarkers. Methods: Eligible studies of miRNAs in peripheral blood distinguishing patients with AD or MCI from cognitively normal controls were identified through standardized search strategies in Medline, PubMed, and Embase. MiRNAs that were differentially expressed were identified and where available their sensitivity and specificity for AD or MCI extracted from the retrieved studies. Results: Eighteen studies investigated the diagnostic value of miRNAs as peripheral biomarkers of AD/MCI. Twenty miRNAs were significantly upregulated and 32 miRNAs downregulated in AD compared to controls in ten AD studies. Nine miRNAs were consistently dysregulated in more than one study. Of the 8 MCI studies, only one miRNA, miR-132, was consistently upregulated in three independent studies. Of the studies that reported diagnostic accuracy data, the majority of miRNA panels and individual miRNAs had a sensitivity and specificity greater than 0.75. Conclusion: Individual studies suggest that miRNAs can differentiate patients with AD/MCI from cognitively normal controls with modest accuracy. However, the literature is constrained by methodological differences between studies, with few studies assessing the same miRNAs. To become potential biomarkers for AD, further studies with standardized study designs for replication and validation are required. Results from this review may help researchers select candidate miRNAs for further investigation.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
1 Clinical & Life Sciences
1.196 Micro & Long Noncoding RNA
1.196.68 MicroRNA in Cancer
Web Of Science research areas
Neurosciences
ESI research areas
Neuroscience & Behavior
Logo image